Contains fulltext : 48198.pdf (publisher's version ) (Closed access)We investigated the effects of NuvaRing on endometrial histology in a 2-year open-label, multicenter trial in 103 premenopausal women aged 18-35 years. Subjects received 26 cycles of treatment, each comprising 3 weeks of ring use followed by a 1-week ring-free period. Endometrial biopsies were taken at baseline, and at cycles 13 (month 12) and 26 (month 24). Normal biopsy results were obtained in all subjects after 24 months of NuvaRing treatment. Atrophic or inactive endometrium and secretory changes were present in the majority of the biopsies after 1 year and 2 years of treatment with the vaginal ring. It was concluded that long-term use of NuvaRing has...
Objective: The objective of this multicentre, non-controlled, open-label study is the evaluation of ...
Background: Progesterone receptor modulators (PRMs) delivered by contraceptive vaginal rings provide...
This study evaluated endometrial histology in women using the once-a-month injectable contraceptive ...
We investigated the effects of NuvaRing on endometrial histology in a 2-year open-label, multicenter...
BACKGROUND: NuvaRing ® is a combined contraceptive vaginal ring designed for 3 weeks continuous use ...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
The contraceptive vaginal ring offers effective contraception that is self-administered, requires le...
Aim: The type of estrogen and progestin as well as their doses, route and regimens of administration...
This study evaluated endometrial histology in women using the once-a-month injectable contraceptive ...
Objective: To determine whether a 3-month contraceptive vaginal ring (CVR) delivering ulipristal ace...
Contains fulltext : 49558.pdf (publisher's version ) (Closed access)The objective ...
Background: Oral contraceptives used for extended periods of time have been extensively studied beca...
Ulipristal acetate (UPA) is a selective progesterone receptor modulator (PRM), which is used as an e...
Contains fulltext : 143499.pdf (publisher's version ) (Closed access)Knowledge on ...
The objective of the study was to evaluate the effect of long-term use of the injectable contracepti...
Objective: The objective of this multicentre, non-controlled, open-label study is the evaluation of ...
Background: Progesterone receptor modulators (PRMs) delivered by contraceptive vaginal rings provide...
This study evaluated endometrial histology in women using the once-a-month injectable contraceptive ...
We investigated the effects of NuvaRing on endometrial histology in a 2-year open-label, multicenter...
BACKGROUND: NuvaRing ® is a combined contraceptive vaginal ring designed for 3 weeks continuous use ...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
The contraceptive vaginal ring offers effective contraception that is self-administered, requires le...
Aim: The type of estrogen and progestin as well as their doses, route and regimens of administration...
This study evaluated endometrial histology in women using the once-a-month injectable contraceptive ...
Objective: To determine whether a 3-month contraceptive vaginal ring (CVR) delivering ulipristal ace...
Contains fulltext : 49558.pdf (publisher's version ) (Closed access)The objective ...
Background: Oral contraceptives used for extended periods of time have been extensively studied beca...
Ulipristal acetate (UPA) is a selective progesterone receptor modulator (PRM), which is used as an e...
Contains fulltext : 143499.pdf (publisher's version ) (Closed access)Knowledge on ...
The objective of the study was to evaluate the effect of long-term use of the injectable contracepti...
Objective: The objective of this multicentre, non-controlled, open-label study is the evaluation of ...
Background: Progesterone receptor modulators (PRMs) delivered by contraceptive vaginal rings provide...
This study evaluated endometrial histology in women using the once-a-month injectable contraceptive ...